Statistics for Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study
Total visits
| views | |
|---|---|
| Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study | 275 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:a0258659-d52b-4c30-a1dc-300e94e73fea | 7 |
Top country views
| views | |
|---|---|
| United States | 203 |
| Germany | 15 |
| Poland | 6 |
| United Kingdom | 5 |
| Russia | 5 |
| Sweden | 5 |
| Ukraine | 5 |
| Canada | 2 |
| China | 2 |
| Italy | 1 |
| Malaysia | 1 |
| Uzbekistan | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 64 |
| Fairfield | 34 |
| Ann Arbor | 26 |
| Houston | 15 |
| Kiez | 14 |
| Jacksonville | 7 |
| White Plains | 7 |
| Cambridge | 6 |
| Kraków | 6 |
| Kiev | 5 |
| Stockholm | 5 |
| Saint Petersburg | 4 |
| Toronto | 2 |
| Washington | 2 |
| Abingdon | 1 |
| Alexandria | 1 |
| Baltimore | 1 |
| Brooklyn | 1 |
| Columbus | 1 |
| Gunzenhausen | 1 |
| Lake Mary | 1 |
| London | 1 |
| Milan | 1 |
| Philadelphia | 1 |
| Reston | 1 |
| San Francisco | 1 |
| Seremban | 1 |
| Tashkent | 1 |
| Woburn | 1 |
| Zhongyuan | 1 |